Adrenal Insufficiency Clinical Trial
Official title:
Inhalation or Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal Axis Suppression in HIV-infected Patients
Rationale: Case reports describe suppression of the hypothalamic-pituitary-adrenal (HPA)
axis caused by local corticosteroids, most often with inhalation corticosteroids. The exact
prevalence is not known. Early recognition is important, because suppression of the HPA-axis
can lead to significant morbidity and mortality. Suppression of the HPA axis might occur
more often when a Cytochrome P450 3A4 (CYP3A4) inhibitor, e.g. ritonavir, is used next to
the local corticosteroid, a combination often used by human immunodeficiency virus
(HIV)-patients. Cortisol can be determined in hair. This non-invasive analysis could help in
diagnosis of suppressed HPA-axis.
Research questions:
Primary objective:
1. How often do inhalation or nasal corticosteroids lead to suppression of the HPA- axis
in HIV-treated patients?
Secondary objectives:
2. Are other variables associated with the HPA-axis suppression?
3. Are cortisol measurements in hair as reliable as serum cortisol or an
Adrenocorticotropic hormone (ACTH) stimulation test to diagnose suppression of the HPA
axis? Study design: cross-sectional explorative study Study population: adults treated
for HIV and using an inhalation or nasal corticosteroid.
Intervention: an ACTH stimulation test, cortisol measurements in blood and hair.
Main study parameters/endpoints:
Proportions of persons with a low morning plasma cortisol or low cortisol after an ACTH
stimulation test. Correlation between cortisol in plasma and hair cortisol.
Nature and extent of the burden and risks associated with participation, benefit and group
relatedness: Each person will be screened with a history and a short physical examination. A
venous cannula will be inserted for obtaining blood for the plasma cortisol and for the ACTH
stimulation test. An ACTH stimulation test has no major complications. A piece of hair is
cut for cortisol hair analysis. The risks and burden are minimal, while the future benefits
could be great since suppression of the endogenous HPA- axis can be associated with
morbidities like hypertension or osteoporosis and can even lead to an adrenal crisis when
the local corticosteroid is stopped.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT03282487 -
Optimising Steroid Replacement in Patients With Adrenal Insufficiency
|
Phase 4 | |
| Not yet recruiting |
NCT05716607 -
Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
|
N/A | |
| Not yet recruiting |
NCT06435481 -
Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics
|
Phase 4 | |
| Recruiting |
NCT03399383 -
Adherence in Chronic Adrenal Insufficiency
|
N/A | |
| Completed |
NCT01428336 -
Value of 25 mcg Cortrosyn Stimulation Test
|
N/A | |
| Completed |
NCT00851942 -
Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test
|
Phase 4 | |
| Withdrawn |
NCT00368381 -
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
|
Phase 4 | |
| Active, not recruiting |
NCT04519580 -
Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
|
||
| Recruiting |
NCT06008184 -
Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids
|
||
| Completed |
NCT03013166 -
THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or Prednisolone
|
||
| Enrolling by invitation |
NCT02282150 -
Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism
|
Phase 4 | |
| Completed |
NCT02934399 -
Dynamic Hormone Diagnostics in Endocrine Disease
|
||
| Completed |
NCT03000231 -
Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
|
||
| Completed |
NCT01960530 -
An Investigational Study of Hydrocortisone
|
Phase 1 | |
| Completed |
NCT00552487 -
Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis
|
N/A | |
| Completed |
NCT00575341 -
Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency
|
Phase 3 | |
| Completed |
NCT00471900 -
Six Months DHEA Treatment in Female Adrenal Failure
|
N/A | |
| Completed |
NCT03294876 -
Rheumatoid Arthritis Adrenal Recovery Study
|
||
| Completed |
NCT03709381 -
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
|
Early Phase 1 | |
| Recruiting |
NCT05639127 -
The Treatment of Adrenal Crisis With Inhaled Prednisolone
|
Early Phase 1 |